Clinical Trial Update: Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating ketamine infusion for symptomatic improvement in severe Borderline Personality Disorder; the study is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Infusion of Ketamine in Severe Borderline Personality Disorder, Borderline Personality Disorder (BPD) | Phase 2 | Status: NOT_YET_RECRUITING